Deals
Bid & Ask: The Deals of the Week
This article is for subscribers only.
1. Japan's Takeda Pharmaceutical (TKPYY) agreed to buy Zurich-based Nycomed for $9.1 billion, in part to cushion the blow of losing patent protection on Actos, its best-selling diabetes pill.
2. The U.S. Treasury Dept. and American International Group (AIG) raised $8.7 billion in a sale of AIG shares, bringing the insurer one step closer to independence after its 2008 bailout.
